RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 468 citations · Minesh Mehta
NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 175 citations · Minesh Mehta
Chronic Stress and Headaches: The Role of the HPA Axis and Autonomic Nervous System.
Biomedicines · 2025 · 51 citations · Marko Bogicevic
2025 focused update of the 2020 ISTH guidelines for management of thrombotic thrombocytopenic purpura.
Journal of thrombosis and haemostasis : JTH · 2025 · 50 citations · Camila Masias
Glioblastoma in adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.
Neuro-oncology · 2025 · 50 citations · Manmeet Ahluwalia, Minesh Mehta
Phase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 146 citations · Manmeet Ahluwalia
Caplacizumab use in immune-mediated thrombotic thrombocytopenic purpura: an international multicentre retrospective Cohort study (The Capla 1000+ project).
EClinicalMedicine · 2025 · 43 citations · Camila Masias
Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial.
Neuro-oncology · 2023 · 133 citations · Minesh Mehta